Clinical Trials Directory

Trials / Completed

CompletedNCT01991275

Intrathecal Morphine in Robot-assisted Prostatectomy

The Efficacy of Intrathecal Morphine in Patients Undergoing Robot-assisted Prostatectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy

Detailed description

Prostatectomy is the treatment of choice for prostate cancer. The robot-assisted prostatectomy is becoming the most popular surgical method for prostate cancer. The small incision after robot-assisted prostatectomy is thought to reduce the postoperative pain. There is few investigations for the strategy to reduce the postoperative pain of robot-assisted prostatectomy. The intrathecal morphine injection is known to reduce postoperative pain for surgeries like hepatectomy, myomectomy and open prostatectomy. This method, however, is not yet studied for the robot-assisted prostatectomy. This study will investigate the efficacy and safety of intrathecal morphine for the patients undergoing robot-assisted prostatectomy.

Conditions

Interventions

TypeNameDescription
DRUGThe intravenous patient-controlled analgesiaThe intravenous injection of morphine using the patient-controlled analgesia machine
DRUGThe intrathecal morphine injectionA single injection of morphine intrathecally

Timeline

Start date
2013-11-01
Primary completion
2014-06-01
Completion
2014-06-01
First posted
2013-11-25
Last updated
2015-07-03

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01991275. Inclusion in this directory is not an endorsement.